CN Patent

CN118146213B — 一种苯并噻唑嘧啶胺类dyrk2抑制剂及其制备方法和应用

Assigned to Jiangsu Tasly Diyi Pharmaceutical Co Ltd · Expires 2024-11-26 · 1y expired

What this patent protects

本发明公开了一种苯并噻唑嘧啶胺类DYRK2抑制剂及其制备方法和应用，本发明的化合物能抑制癌细胞的增殖，可用于制备治疗癌症或肿瘤相关疾病药物。

USPTO Abstract

本发明公开了一种苯并噻唑嘧啶胺类DYRK2抑制剂及其制备方法和应用，本发明的化合物能抑制癌细胞的增殖，可用于制备治疗癌症或肿瘤相关疾病药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN118146213B
Jurisdiction
CN
Classification
—
Expires
2024-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Tasly Diyi Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.